Regeneron Pharmaceuticals
A Computational Scientist in the Molecular Profiling and Data Science Department at Regeneron conducts independent and collaborative research applying computational methods to multi-omics and immuno-oncology, contributing to studies that range from basic research to translational applications. The role involves developing novel computational approaches using internal and external big data to advance target identification, biomarker discovery, and clinical profiling. The position is embedded in a multidisciplinary team at the intersection of multi-omics, technology development, and machine learning, with work that directly impacts patient outcomes.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Postdoctoral Researcher in Computational Immuno-oncology
University of Helsinki
Bioinformatics Research Scientist
St. Jude Children's Research Hospital
Senior Scientist
BeOne Medicines
Director of IO Bioinformatics
AstraZeneca
Translational Scientist (Senior)
Bioptimus
Postdoctoral Fellow in Pediatrics
PeopleAdmin